Financial conflicts of interest and study results in environmental and occupational health research

Journal of Occupational and Environmental Medicine

Volumn 58, Issue 3, 2016, Pages 238-247

  Friedman, Lee ^a   Friedman, Michael ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARMY; CONFLICT OF INTEREST; CONTROLLED STUDY; EMPLOYMENT; FUNDING; HUMAN; LOGISTIC REGRESSION ANALYSIS; MODEL; OCCUPATIONAL HEALTH; ODDS RATIO; ORGANIZATION; BIBLIOMETRICS; ECONOMICS; ENVIRONMENTAL HEALTH; ETHICS; FINANCIAL MANAGEMENT; GOVERNMENT; INDUSTRY; PUBLISHING; RESEARCH ETHICS;

BIBLIOMETRICS; CONFLICT OF INTEREST; ENVIRONMENTAL HEALTH; ETHICS, RESEARCH; GOVERNMENT AGENCIES; HUMANS; INDUSTRY; OCCUPATIONAL HEALTH; PUBLICATION BIAS; RESEARCH SUPPORT AS TOPIC;

EID: 84963684590     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000671     Document Type: Article

References (40)

1. Steneck NH. Fostering integrity in research: definitions, current knowledge, and future directions. Sci Eng Ethics. 2006; 12: 53-74
2. Angell M. The Truth About the Drug Companies: How They Deceive Us and What to do About it. Random House: Inc., New York; 2004
3. Parascandola M. A turning point for conflicts of interest: the controversy over the National Academy of Sciences first conflicts of interest disclosure policy. J Clin Oncol. 2007; 25: 3774-3779
4. IOM (Institute of Medicine). Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: The National Academies Press; 2009
5. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993; 329: 573-576
6. Kahn JO, Cherng DW, Mayer K, Murray H, Lagakos S. Evaluation of HIV-1 Immunogen, an immunologic modifier, administered to patients infected with HIV having 300 to 549 X106/L CD4 counts: a randomized controlled trial. JAMA. 2000; 284: 2193-2202
7. Martinson BC. Institutions expectations for researchers self-funding, federal grant holding, and private industry involvement: manifold drivers of self-interest and researcher behavior. Acad Med. 2009; 84: 1491-1499
8. Stelfox HT, Chua G, ORourke K, Detsky A. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998; 338: 101-106
9. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturersupported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med. 1994; 154: 157-163
10. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003; 289: 454-465
11. Davidson RA. Source of funding and outcome of clinical trials. J Gen Intern Med. 1986; 1: 155-158
12. Flacco ME, Manzoli L, Boccia S, et al. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor. J Clin Epidemiol. 2015; 68: 811-820
13. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012; 12: MR000033
14. Roseman M, Milette K, Bero LA, et al. Reporting of conflicts of interest in meta-Analyses of trials of pharmacological treatments. JAMA. 2011; 305: 1008-1017
15. Friedman L, Richter ED. Relationship between conflicts of interest and research results. J Gen Int Med. 2004; 19: 51-56
16. Okike K, Kocher MS, Mehlman CT, Bhandari M. Industry-sponsored research. Injury. 2008; 39: 666-680
17. Rowe S, Alexander N, Clydesdale FM, et al. Funding food science and nutrition research: financial conflicts and scientific integrity. Am J Clin Nutr. 2009; 89: 1285-1291
18. Shrader-Frechette K. Climate change, nuclear economics, and conflicts of interest. Sci Eng Ethics. 2011; 17: 75-107
19. Baur X, Budnik LT, Ruff K, Egilman DS, Lemen RA, Soskolne CL. Ethics, morality, and conflicting interests: how questionable professional integrity in some scientists supports global corporate influence in public health. Int J Occup Environ Health. 2015; 21: 172-175
20. Pickar JH. Conflicts of interest in government-funded studies. Climacteric. 2015; 18: 1-4
21. Hardell L, Walker MJ, Walhjalt B, Friedman LS, Richter ED. Secret ties to industry and conflicting interests in cancer research. Am J Ind Med. 2007; 50: 227-233
22. Melnick RL, Ward JM, Huff J.War on carcinogens: industry disputes human relevance of chemicals causing cancer in laboratory animals based on unproven hypotheses, using kidney tumors as an example. Int J Occup Environ Health. 2013; 19: 255-260
23. ISI Web of Knowledge. Journal Citation Reports. Available at: http://adminapps. webofknowledge.com.proxy.cc.uic.edu/JCR/JCRPointOfEntryU Home&SIDU3CgLeohQuVZAvW3b8qO. Accessed March 17, 2015
24. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. 2004. Available at: http://www.icmje.org/. Accessed March 17, 2015
25. Bhargava N, Qureshi J, Vakil N. Funding source and conflict of interest disclosures by authors and editors in gastroenterology specialty journals. Am J Gastroenterol. 2007; 102: 1146-1150
26. Bosetti F, Toscano CD. Is it time to standardize ethics guiding the peer review process Lipids. 2008; 43: 107-108
27. Broome M, Dougherty MC, Freda MC, Kearney MH, Baggs JG. Ethical concerns of nursing reviewers: an international survey. Nurs Ethics. 2010; 17: 741-748
28. Dyer O. Former journal editor had potential conflicts of interest in nine of 10 articles he authored. BMJ. 2014; 349: g7589
29. Gleicher N. Avoiding currently unavoidable conflicts of interest in medical publishing by transparent peer review. Reprod Biomed Online. 2013; 26: 411-415
30. Grandjean P, Ozonoff D. Transparency and translation of science in a modern world. Environ Health. 2013; 12: 70
31. Steinbrook R, Lo B. Medical journals and conflicts of interest. J Law Med Ethics. 2012; 40: 488-499
32. Buchkowsky SS, Jewesson PJ. Industry sponsorship and authorship of clinical trials over 20 years. Ann Pharmacother. 2004; 38: 579-585
33. Tong EK, Glantz SA. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Circulation. 2007; 116: 1845-1854
34. Schafer A. Biomedical conflicts of interest: a defence of the sequestration thesis-learning from the cases of Nancy Olivieri and David Healy. J Med Ethics. 2004; 30: 8-24
35. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B. Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ. 2003; 326: 1171-1173
36. Wislar JS, Flanagin A, Fontanarosa PB, Deangelis CD. Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ. 2011; 343: d6128
37. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available at: www.cochrane-handbook.org. Accessed October 7, 2015
38. Boumil MM1, Salem DN. In ... and out: open access publishing in scientific journals. Qual Manag Health Care. 2014; 23: 133-137
39. Oleinik A. Conflict(s) of interest in peer review: its origins and possible solutions. Sci Eng Ethics. 2014; 20: 55-75
40. Califf RM, McCall J, Harrington RA. Assessing research results in the medical literature: trust but verify. JAMA Intern Med. 2013; 173: 1053-1055